Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus

Atherosclerosis

Volumn 208, Issue 1, 2010, Pages 264-269

  Feng, Bo ^a   Chen, Yinghua ^a   Luo, Yun ^a   Chen, Ming ^a   Li, Xu ^a   Ni, Yafang ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Brachial ankle pulse wave velocity; Endothelium dependent dilation; Microparticle; Type 2 diabetes mellitus

Indexed keywords

ANTIGEN; CD31 ANTIGEN; CD42 ANTIGEN; CD51 ANTIGEN; HEMOGLOBIN A1C; INSULIN; LIPOCORTIN 5; METFORMIN; SULFONYLUREA; UNCLASSIFIED DRUG;

ADULT; ANKLE BRACHIAL INDEX; ARTERY BLOOD FLOW; ARTERY COMPLIANCE; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE MICROPARTICLE; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PULSE WAVE; VASCULAR DISEASE;

ARTERIES; CELL-DERIVED MICROPARTICLES; DIABETES MELLITUS, TYPE 2; ELASTICITY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 73449104682     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.06.037     Document Type: Article

References (23)

1. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 13 (1967) 269-288
2. Leroyer A.S., Tedgui A., and Boulanger C.M. Microparticles and type 2 diabetes. Diabetes Metab Suppl. 1 (2008) S27-S32
3. Bernard S., Loffroy R., Sérusclat A., et al. Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). Atherosclerosis 20 (2009) 429-435
4. Bernal-Mizrachi L., Jy W., Jimenez J.J., et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145 (2003) 962-970
5. Agouni A., Lagrue-Lak-Hal A.H., Ducluzeau P.H., et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 173 (2008) 1210-1219
6. Pirro M., Schillaci G., Paltriccia R., et al. Increased ratio of CD31+/CD42- microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler Thromb Vasc Biol 26 (2006) 2530-2535
7. Nomura S., Inami N., Kimura Y., et al. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens 21 (2007) 38-44
8. Bidot L., Jy W., BidotC Jr., et al. Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost 6 (2008) 913-919
9. Stehouwer C.D., Henry R.M., and Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 51 (2008) 527-539
10. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 (2004) III27-III32
11. Chirinos J.A., Heresi G.A., Velasquez H., et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 45 (2005) 1467-1471
12. Sabatier F., Darmon P., Hugel B., et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes 51 (2002) 2840-2845
13. Combes V., Simon A.C., Grau G.E., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 104 (1999) 93-102
14. Jimenez J.J., Jy W., Mauro L.M., et al. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 112 (2001) 81-90
15. Jimenez J.J., Jy W., Mauro L.M., et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109 (2003) 175-180
16. Abid Hussein M.N., Meesters E.W., Osmanovic N., et al. Antigenic characterization of endothelial cell derived microparticles and their detection ex vivo. J Thromb Haemost 1 (2003) 2434-2443
17. Arteaga R.B., Chirinos J.A., Soriano A.O., et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 98 (2006) 70-74
18. Nomura S., Shouzu A., Omolo S., et al. Activated platelet and oxidized LDL induce endothelial membrane vesiculation: clinical significance of endothelial cell-derived microparticles in patients with type 2 diabetes. Clin Appl Thromb Hemost 10 (2004) 205-215
19. Brodsky S.V., Zhang F., Nasjletti A., et al. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol 286 (2004) H1910-H1915
20. Densmore J.C., Signorino P.R., Ou J., et al. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock 26 (2006) 464-471
21. Schmitt M., Avolio A., Qasem A., et al. Basal NO locally modulates human iliac artery function in vivo. Hypertension 46 (2005) 227-231
22. Shimazu T., Inami N., Satoh D., et al. Effect of acarbose on platelet-derived microparticles, soluble selectins, and adiponectin in diabetic patients. J Thromb Thrombolysis 10 (2009) [Epub ahead of print]
23. Chironi G., Simon A., Hugel B., et al. Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects. Arterioscler Thromb Vasc Biol 26 (2006) 2775-2780